This trial is for people who have developed type 1 diabetes after taking part in another trial testing a different diabetes treatment. The people in this trial will receive teplizumab, which may help to prevent or delay the onset of type 1 diabetes.
- Type 1 Diabetes
1 Primary · 7 Secondary · Reporting Duration: 78 weeks
1 Treatment Group
1 of 1
30 Total Participants · 1 Treatment Group
Primary Treatment: teplizumab · No Placebo Group · Phase 2
Who is running the clinical trial?
Age Any Age · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
- "My son was diagnosed on the 14th of February 2022. My heart breaks for him every day. If there is any hope, once safe, I owe it to him to do all I can to get him the hrlp"
Frequently Asked Questions
Could you please tell us how many different places are coordinating this research?
"To reduce inconvenience for participants, this clinical trial has 5 different enrolment sites. These are located in Nashville, Gainesville and New Haven as well as other places." - Anonymous Online Contributor
How many people have been selected to participate in this research project?
"Yes, this is an ongoing study that is actively recruiting patients. The trial was established on March 2nd, 2020 and the most recent update was on September 27th, 2022. They are looking for 30 individuals to participate at 5 different sites." - Anonymous Online Contributor
Is this the first time that teplizumab has been used in a clinical trial?
"Teplizumab was first studied in 2019 at CHRU de Besancon-Hopital Jean Minjoz-(Site 511). So far, there have been six completed studies. There are presently two live studies being conducted, with a large number of these studies taking place in Nashville, Tennessee." - Anonymous Online Contributor
When might teplizumab be available to the general public?
"While there is some data suggesting teplizumab is safe, as this is only a Phase 2 trial, no efficacy has been proven yet. Therefore, it receives a score of 2." - Anonymous Online Contributor
To your knowledge, is this a groundbreaking study?
"There are 66 cities and 9 countries with active teplizumab clinical trials. The first study was conducted in 2019 by Provention Bio, Inc. This initial trial had 300 patients and completed its Phase 3 drug approval stage. In the 2 years since 2019, 6 more trials have been completed." - Anonymous Online Contributor
Are we still looking for volunteers to participate in this research?
"If you're interested, this trial could use your help. According to the latest update on clinicaltrials.gov (September 27th, 2020), the study is still looking for willing participants." - Anonymous Online Contributor